Alzheimer's disease (AD), a common type of neurodegenerative disorders, is characterized by progressive cognition and behaviour impairment. The pathological hallmarks of AD are extracellular amyloidβ (Aβ) peptide plaques and intracellular neurofibrillary tangles formed by hyperphosphorylated tau protein (Holtzman et al., 2011).According to the World Alzheimer Report 2018, 82 million people will be diagnosed with dementia and the estimated worldwide cost will rise to $2 trillion by 2030 (Patterson, 2018), presenting a great challenge and significant burden on the ageing society. Though the pathogenesis of AD remains unclear, accumulating studies have demonstrated that microbiome contributes to AD (Miklossy et al., 2006;Poole et al., 2013;Riviere et al., 2002). Firstly, several microbiota and/or lipopolysaccharide (LPS) have been detected in the brain tissue of AD patients, such as Chlamydia pneumoniae (Balin et al.,